» Articles » PMID: 17409972

Increasing Osteoblastic Lesions As a Manifestation of a Major Response to Gefitinib

Overview
Journal J Thorac Oncol
Publisher Elsevier
Date 2007 Apr 6
PMID 17409972
Citations 4
Authors
Affiliations
Soon will be listed here.
Citing Articles

Fracture Risk Evaluation of Bone Metastases: A Burning Issue.

Confavreux C, Follet H, Mitton D, Pialat J, Clezardin P Cancers (Basel). 2021; 13(22).

PMID: 34830865 PMC: 8616502. DOI: 10.3390/cancers13225711.


Early and Complete Response of Bone Metastases, Documented by FDG-PET/CT Scan, in a Patient With NSCLC.

Rossi D, Giordani P, Alessandroni P, Catalano V, Casadei V, Baldelli A World J Oncol. 2017; 3(1):39-41.

PMID: 29147277 PMC: 5649835. DOI: 10.4021/wjon441w.


Oral Targeted Therapies and Central Nervous System (CNS) Metastases.

Gabay M, Wirth S, Stachnik J, Overley C, Long K, Bressler L CNS Drugs. 2015; 29(11):935-52.

PMID: 26563196 DOI: 10.1007/s40263-015-0283-6.


Mutational profiling of bone metastases from lung adenocarcinoma: results of a prospective study (POUMOS-TEC).

Confavreux C, Girard N, Pialat J, Bringuier P, Devouassoux-Shisheboran M, Rousseau J Bonekey Rep. 2014; 3:580.

PMID: 25328676 PMC: 4181073. DOI: 10.1038/bonekey.2014.75.